Sodium-glucose transporter 2 inhibitors and their antiarrhythmic role: New insights and future perspective
Authors
Diana-Ioana Prația-Aron
Emergency Institute for Cardiovascular Diseases and Transplantation of Targu Mures, Targu Mures, Romania
Dan-Alexandru Cozac
Emergency Institute for Cardiovascular Diseases and Transplantation of Targu Mures, Targu Mures, Romania
Physiology Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, Romania
Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, Romania
Alina Scridon
Physiology Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, Romania
Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, Romania
Language: English
Page range: 262 - 267
Submitted on: Jul 27, 2025
Accepted on: Aug 27, 2025
Published on: Dec 11, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2025 Diana-Ioana Prația-Aron, Dan-Alexandru Cozac, Alina Scridon, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.